Press releases

Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline

Proceeds to advance three late-stage programs towards registration, prepare for commercialization and progress the company’s gene therapy platform

Read more

Orchard Therapeutics Appoints Jon Ellis to Board of Directors

Orchard Therapeutics today announced the appointment of Jon Ellis, Ph.D. as GSK’s designated representative to its board of directors. Dr. Ellis is currently vice president and head of science & technology licensing at GlaxoSmithKline (GSK)

Read more

Orchard Therapeutics Appoints Joanne Beck, Ph.D. to Board of Directors

Orchard Therapeutics today announced the appointment of Joanne Beck, Ph.D., to its board of directors. Dr. Beck is currently the executive vice president of pharmaceutical development and operations and a member of the executive committee at Celgene

Read more

Orchard Therapeutics Appoints Jim Geraghty as Chairman of its Board of Directors

Orchard Therapeutics today announced the appointment of Jim Geraghty as chairman of its board of directors. Ben Auspitz, a partner at F-Prime Capital, who served as Orchard’s chairman since 2016, will transition from his current role on the board

Read more

Orchard Therapeutics Announces Appointments of Marc Dunoyer and Charlie Rowland to Board of Directors

Orchard Therapeutics today announced the appointments of Marc Dunoyer and Charlie Rowland to its board of directors as independent directors

Read more